![Maggie Shafmaster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maggie Shafmaster
Directeur/Bestuurslid bij
PROMIS NEUROSCIENCES, INC.
Vermogen: 4 M $ op 31-05-2026
Profiel
Maggie Shafmaster currently works at ProMIS Neurosciences, Inc., as Lead Independent Director from 2021.
Dr. Shafmaster also formerly worked at Genzyme Corp., as Chief Patent Counsel & Senior Vice President and Sanofi Pasteur Ltd., as Chief Patent Counsel & Vice President.
Dr. Shafmaster received her graduate degree from New York Law School, undergraduate degree from the University of California, and doctorate degree from Cornell University Graduate School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-05-2026 | 345.380 ( 3,85% ) | 4 M $ | 31-05-2026 |
Actieve functies van Maggie Shafmaster
| Bedrijven | Functie | Begin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur/Bestuurslid | 22-09-2021 |
Eerdere bekende functies van Maggie Shafmaster
| Bedrijven | Functie | Einde |
|---|---|---|
Sanofi Pasteur Ltd.
 Sanofi Pasteur Ltd. BiotechnologyHealth Technology Develops, manufactures and markets vaccines and immunotherapeutic products | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Opleiding van Maggie Shafmaster
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Sanofi Pasteur Ltd.
Sanofi Pasteur Ltd. BiotechnologyHealth Technology Develops, manufactures and markets vaccines and immunotherapeutic products | Health Technology |
New York Law School
 New York Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University Graduate School
 Cornell University Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
